期刊文献+

TAFI在2型糖尿病肾病肾损伤发病机制中的作用 被引量:5

Role of Plasma TAFI in the Pathogenesis of Kidney Injury Induced by Type 2 Diabetes
下载PDF
导出
摘要 目的:探讨血浆凝血酶激活的纤溶抑制物(TAFI)在2型糖尿病(T2DM)大鼠肾损伤发病机制中的作用。方法:选用雄性Wistar大鼠36只,随机分成3组(正常组、糖尿病假手术组、糖尿病手术组),每组12只。正常组予以普通饲料喂养并腹腔注射柠檬酸缓冲液;另外2组予以高糖高脂饲料喂养及腹腔注射链脲佐菌素(STZ),糖尿病手术组予以右肾切除术诱导T2DM肾病模型。检测3组血生化、凝血指标和尿蛋白,同时观察肾脏病变情况。结果:糖尿病手术组的体重、肾指数、血糖(FBG)、胰岛素(INS)、肌酐清除率(Ccr)、血脂、24 h尿蛋白、TAFI等水平明显高于另外2组,肾脏HE染色显示上皮细胞肿胀,水样变、空泡变性,肾小管扩张,肾小球基底膜增厚,系膜区增宽,细胞外基质增多。肾指数、损伤评分、肾小球面积及体积与另外2组相比,均有统计学意义。结论:三联法(高糖高脂饮食+单侧肾脏切除+小剂量链脉佐菌素STZ)能建立稳定的符合T2DM肾病大鼠模型;TAFI参与T2DM大鼠肾损伤发生发展。 Objective: To explore the role of plasma thrombin activated fibrinolysis inhibitor( TAFI) in the pathogenesis of type 2 diabetic mellitus( T2DM)-induced kidney injury in rats. Methods Thirty-six one-month-old Wistar rats were randomly divided into three groups( normal diet group,T2 DM sham operation group and T2 DM operation group),12 in each group. The rats in normal diet group were fed on common fodder and intraperitoneally injected with critric acid buffer,and those in other two groups were fed on high fat and sugar diet and then intraperitoneally injected with STZ. The rats in T2 DM sham operation group were given sham operation,and those in T2 DM operation group were given surgical removal of the right kidney to induce the model of T2DM-induced nephropathy. The blood biochemistry indicators,blood coagulation index and urine protein were tested,and at the same time,renal lesions were observed by HE staining. Result: Weight,kidney index,fasting blood glucose( FBG),insulin( INS),creatinine clearance rate( Ccr),blood lipid,24-h urine protein,and TAFI levels in T2 DM operation group were obviously higher than those in other two groups. The pathological changes of the kidneys in T2 DM operation group were significantly aggravated as compared with other two groups. Conduction: The triplex process( high fat and sugar diet + unilateral nephrectomy + a low dose of STZ) can establish the steady rat model which accords with the characteristics of T2DM-induced nephropathy. TAFI may participate in the development of the kidney injury induced by T2 DM in rats.
出处 《内科急危重症杂志》 2016年第4期305-307,共3页 Journal of Critical Care In Internal Medicine
基金 湖北省自然科学基金重点项目(No:2013CFA066) 2015年度“黄鹤英才(医疗卫生)计划” 2015年度武汉市创新人才开发资金项目
关键词 2型糖尿病 肾病 大鼠模型 TAFI Type 2 diabetes Nephropathy rat model TAFI
  • 相关文献

参考文献6

  • 1张雨薇,童南伟.《中国成人糖尿病肾病临床诊断的专家共识》解读[J].中国实用内科杂志,2015,35(2):139-142. 被引量:28
  • 2裴娟,张燕林.积极降压在防治糖尿病肾病中的作用[J].内科急危重症杂志,2014,20(4):223-226. 被引量:6
  • 3刘志红.糖尿病肾病的治疗[J].中国实用内科杂志,2006,26(3):322-323. 被引量:102
  • 4Sun L,Zhang D,Liu F,et al. 1,ow-dose paclitaxcl ameliorates fibrosis in the remnant kidney model |/5, down-regnlaling miR-192 [ J ]. J Pathol, 2011,225 ( 3 ) : 364-377.
  • 5Zhcng C, Li X, Kong C ,et al. Effect of single nucleotide tolymorphisnl in ttlrombin-activatable fibrinolysis inhibitor on lhe risk of diabetic macrovascular disease[ J ]. Blood Coagul Fibrinolysis, 2015,26 ( 2 ) : 185-190.
  • 6Xu CW, Wu XB, Ma XL, eta]. Genetic variation in thromlin-aetivat- able fibrinolysis inhibitor is associated with tile risk of diabetic ne- phrofathy [ J ]. J Endocrinol Invest ,2012,35 ( 7 ) :620-624.

二级参考文献27

  • 1KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease [ J ]. Am J Kidney Dis ,2007,49 ( 2 suppl 2 ) : S12-S154.
  • 2Bakris GL,Weir MR,Shanifar S,et al. Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL Study [ J ]. Arch Intern Med,2003,163 ( 13 ) : 1555-1565.
  • 3Shankar A, Klein R, Klein BE. Relationship between low-normal blood pressure and kidney disease in type 1 diabetes. Hypertension [ J ]. 2007,49( 1 ) :48-54.
  • 4UKPDS:UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38[J]. BMJ. 1998,317(7160) :703-713.
  • 5Staessen JA, Fagard R,Thijs L,et al. Randomised double-blind com- parison of placebo and active treatment for older patients with isolated systolic hypertension The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. [ J ]. Lancet, 1997,350 (9080) :757-764.
  • 6Bakris GL,Williams M,Dworkin L,et al. Preserving renal function in a- dults with hypertension and diabetes : a consensus approach. National kid- ney foundation hypertension and diabetes executive committees working group[J]. Am J Kidney Dis,20O,36(3):6464561.
  • 7Bakris GL, Sowers JR. American Society of Hypertension Writing Group, ASH position paper: treatment of hypertension in patients with diabetes-an update[ J]. J Clini Hypertens ,2008,10(9 ) : 707-713.
  • 8American Diabetes Association, Standards of Medical Care in Diabe- tes-2009 [ J ]. Diabetes Care January, 2009,32 ( suppl 1 ) : S 13 -S61.
  • 9KDIGO BP Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease [ J ]. Kidney Int Supp1,2012,2(5) :337414.
  • 10James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the Eighth Joint National Committee (JNC 8),2014,311 (5):507-520.

共引文献133

同被引文献33

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部